RxDoctor Payments Data

Deborah Shultz, MD

General Practice · Tampa, FLNPI 1154341014

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,354 and has fallen 95.2% since, to $64 in 2022. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,880in general payments, 2019–2025

Across 233 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$890
  • Amgen$395
  • AbbVie$311
  • GSK$286
  • Merz North America, Inc.$274
  • Boehringer Ingelheim$249
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,865100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,880 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Medicare billing

Part B allowed, 2024
$7,535
Medicare patients
64
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone54$451
Albuterol Sulfate HfaAlbuterol Sulfate11$402
Gabapentin21$308
Levothyroxine Sodium22$217
Cefdinir12$211
Fluticasone Propionate15$205
Atorvastatin Calcium19$166
Omeprazole14$163
Rosuvastatin Calcium21$150
Metformin Hcl17$112
Lisinopril22$109
Amlodipine Besylate15$98
Azithromycin20$76

Paid to pharmacies, not to this prescriber.

Other general practice in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →